Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DGI BioTechnologies and Novo Nordisk enter collaboration for cancer agents

Jan. 10, 2002

Antisense oligonucleotide targeting Ki-ras as an approach to colorectal cancer

Jan. 10, 2002

Endothelial cell-specific inhibition of protein synthesis demonstrated for tumstatin

Jan. 10, 2002

Prescient NeuroPharma licenses anhydrovinblastine to Access Oncology

Jan. 10, 2002

Study protocol changes following early positive results for Gleevec in CML

Jan. 9, 2002

Idec's BLA for Zevalin radioimmunotherapy approvable according to FDA

Jan. 9, 2002

Millennium initiates phase I clinical program of MLN-341 in combination with Taxotere

Jan. 9, 2002

Antitumor activity demonstrated for new series of caprolactam carbonates

Jan. 9, 2002

Study demonstrates safety, preliminary efficacy of squalamine as 120-hour infusion

Jan. 9, 2002

Geron and Genetic Therapy enter licensing agreement to develop cancer therapy

Jan. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...